Eli Lilly's Omvoh (mirikizumab) has shown durable disease clearance over four years in patients with moderately to severely ...

Add Yahoo as a preferred source to see more of our stories on Google. “Debilitating digestive issues dominated my life because I couldn’t go longer than a half hour without going to the bathroom,” ...

GRAND RAPIDS, Mich. — If the Crohn’s & Colitis Foundation has anything to say about it, a cure for Crohn’s, Ulcerative Colitis, and many other conditions could be right around the corner. And for ...

A review of microscopic colitis, a chronic, intermittent inflammatory bowel disease that predominantly affects older women and typically presents with frequent watery, non-bloody stools.

New long-term data from Eli Lilly and Company (NYSE: LLY) show patients with moderately to severely active ulcerative colitis (UC) treated with Omvoh (mirikizumab-mrkz) achieved durable disease ...

How Does Tremfya Work for Ulcerative Colitis? Tremfya is a monoclonal antibody that reduces inflammation. The main ingredient in Tremfya is a medicine called guselkumab. This medicine blocks a ...

For some people, relief can last years. For others, only a few weeks. Learn what to do to stay in remission for as long as possible.

LUCENT-3 trial open-label extension data show 63.5% of adults with ulcerative colitis administered mirikizumab (Omvoh) who ...

What Is Infusion for Ulcerative Colitis? If your doctor has recommended infusion therapy, this is probably because standard treatment hasn’t helped relieve symptoms caused by moderate-to-severe ...

Arthritis is the most common nonintestinal complication for people with ulcerative colitis (UC). These tips can help stave it ...

Take Steps is a walk event that brings communities together to support people with inflammatory bowel disease (IBD) and their families. The event is happening on Saturday, June 8th, at 10 a.m. at ...